Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomised, Double-blind Trial of Icatibant Compared to Placebo in Patients With Early Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Infection

NCT05407597 is registered in ClinicalTrials.gov with Belfast Health and Social Care Trust as lead sponsor.

NCT NCT05407597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05407597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomised, Double-blind Trial of Icatibant Compared to Placebo in Patients With Early Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Infection
Lead sponsor
Belfast Health and Social Care Trust
Phase
Phase 2/3
Overall status
Completed
Start date
May 16, 2022
Completion date
July 7, 2023
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars cov 2 infection